Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Acute Migraine
Age Range:
18 to 75
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This research study is evaluating an investigational medication called Elismetrep (K-304) for the acute treatment of migraine. Researchers are studying the safety and effectiveness of Elismetrep in adults who experience migraine with or without aura.
Qualifications
You may be able to join if you:
Are 18 to 75 years of age
Have a history of migraine with or without aura for at least one year
Experience migraine attacks on a recurring basis
Are willing to use an electronic diary on your own smartphone device during the study
Are willing to treat one qualifying migraine attack with study medication
FEATURED STUDIES
Adults with osteoarthritis (OA) knee pain may qualify for a research study evaluating an investigational medication for chronic pain relief.
Adults 18 to 75 years of age may qualify for a research study evaluating an investigational medication for migraine attacks.
Adults ages 18 to 70 who experience episodic migraine may qualify for a clinical research study evaluating an investigational medication […]
Adults 18 to younger than 65 years of age living with overweight or obesity may qualify for a clinical research […]
A vaccine research study is expected to open for enrollment in the coming weeks. Join our notification list to be […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]